首页TWST • NASDAQ
add
Twist Bioscience Corp
昨日收盘价
$46.40
当日价格范围
$45.81 - $47.50
年度波幅
$23.07 - $60.90
市值
25.03亿 USD
平均交易量
82.11万
市盈率
-
股息率
-
主要交易所
NASDAQ
财务信息
损益表
收入
净收入
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 8471.00万 | 26.53% |
经营支出 | 7427.60万 | 9.52% |
净收入 | -3465.50万 | 25.06% |
净利润率 | -40.91 | 40.78% |
每股收益 | -0.59 | 20.94% |
息税折旧摊销前利润 | -3198.70万 | 10.40% |
有效税率 | 0.28% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 2.76亿 | -17.84% |
总资产 | 6.14亿 | -20.88% |
负债总额 | 1.42亿 | -7.41% |
权益总额 | 4.73亿 | — |
发行在外的股份 | 5935.64万 | — |
市净率 | 5.78 | — |
资产回报率 | -14.39% | — |
资本回报率 | -15.86% | — |
现金流
现金净变动
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | -3465.50万 | 25.06% |
来自运营的现金 | -1532.00万 | 26.00% |
投资现金 | -128.50万 | 42.81% |
融资现金 | 362.70万 | 720.59% |
现金净变动 | -1290.50万 | 42.79% |
自由现金流 | -650.90万 | 34.40% |
简介
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
CEO
成立时间
2013
员工数量
923
